Chronic kidney disease (CKD) patients under hemodialysis show a higher risk of cardiovascular (CV) mortality and morbidity than the general population. This study aims to identify genetic markers that could explain the increased CV risk in hemodialysis.

Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis / Terranegra, Annalisa; Arcidiacono, Teresa; Macrina, Lorenza; Brasacchio, Caterina; Pivari, Francesca; Mingione, Alessandra; Tomei, Sara; Mezzavilla, Massimo; Silcock, Lee; Cozzolino, Mario; Palmieri, Nicola; Conte, Ferruccio; Sirtori, Marcella; Rubinacci, Alessandro; Soldati, Laura; Vezzoli, Giuseppe. - In: CLINICAL KIDNEY JOURNAL. - ISSN 2048-8505. - 13:4(2020), pp. 666-673-673. [10.1093/ckj/sfz182]

Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis

Vezzoli, Giuseppe
2020-01-01

Abstract

Chronic kidney disease (CKD) patients under hemodialysis show a higher risk of cardiovascular (CV) mortality and morbidity than the general population. This study aims to identify genetic markers that could explain the increased CV risk in hemodialysis.
2020
cardiovascular disease
chronic kidney disease
gene polymorphism
genetics
hemodialysis
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/103766
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact